CERN Accelerating science

CERN Document Server Sök i 6 journaler efter:  Sökningen tog 0.56 sekunder. 
1.
Production, isolation and characterization of radiochemically pure 163Ho samples for the ECHo-project / Dorrer, Holger (Mainz U. ; Bern U. ; PSI, Villigen) ; Chrysalidis, Katerina (Mainz U.) ; Goodacre, Thomas Day (CERN ; Manchester U.) ; Düllmann, Christoph E (Mainz U. ; Darmstadt, GS) ; Eberhardt, Klaus (Mainz U.) ; Enss, Christian (Heidelberg U.) ; Gastaldo, Loredana (Heidelberg U.) ; Haas, Raphael (Mainz U.) ; Harding, Jonathan (Mainz U. ; Cardiff U.) ; Hassel, Clemens (Heidelberg U.) et al.
Several experiments on the study of the electron neutrino mass are based on high-statistics measurements of the energy spectrum following electron capture of the radionuclide $^{163}$Ho. They rely on the availability of large, radiochemically pure samples of $^{163}$Ho. [...]
2018 - 13 p. - Published in : Radiochim. Acta 106 (2018) 535-547
2.
Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with $^152$Tb-DOTATOC / Baum, Richard P (Zentralklinik, Bad Berka) ; Singh, Aviral (Zerntralklinik, Bad Berka) ; Benešová, Martina (PSI, Villigen ; ETH, Zurich (main)) ; Vermeulen, Christiaan (PSI, Villigen) ; Gnesin, Silvano (Lausanne U. Hospital, Lausanne) ; Köster, Ulli (Laue-Langevin Inst.) ; Johnston, Karl (CERN) ; Müller, Dirk (Zentralklinik, Bad Berka) ; Senftleben, Stefan (Zentralklinik, Bad Berka) ; Kulkarni, Harshad R (Zentralklinik, Bad Berka) et al.
The existence of theragnostic pairs of radionuclides allows the preparation of radiopharmaceuticals for diagnostic and therapeutic purposes. Radiolanthanides, such as $^{177}$Lu, are successfully used for therapeutic purposes; however, a perfect diagnostic match is currently not available for clinical use. [...]
2017 - 9 p. - Published in : Dalton Trans. 46 (2017) 14638-14646 External links: Fulltext; Fulltext; Fulltext; Fulltext
3.
Preclinical in vivo application of $^{152}$Tb-DOTANOC: a radiolanthanide for PET imaging / Müller, Cristina (PSI, Villigen) ; Vermeulen, Christiaan (PSI, Villigen) ; Johnston, Karl (CERN) ; Köster, Ulli (Laue-Langevin Inst.) ; Schmid, Raffaella (PSI, Villigen) ; Türler, Andreas (PSI, Villigen ; Bern U.) ; van der Meulen, Nicholas P (PSI, Villigen)
Background:Terbium has attracted the attention of researchers and physicians due to the existence of four medically interesting radionuclides, potentially useful for SPECT and PET imaging, as well as for α- and $β^−$-radionuclide therapy. The aim of this study was to produce $^{152}$Tb $(T_{1/2} = 17.5 h, E_{β+av} = 1140 keV)$ and evaluate it in a preclinical setting in order to demonstrate its potential for PET imaging. [...]
2016 - 10 p. - Published in : EJNMMI Res. 6 (2016) 35 Fulltext: PDF;
4.
Polonium evaporation from dilute liquid metal solutions / Rizzi, Matthias (PSI, Villigen ; U. Bern (main)) ; Neuhausen, Jörg (PSI, Villigen) ; Eichler, Robert (PSI, Villigen ; U. Bern (main)) ; Türler, Andreas (PSI, Villigen ; U. Bern (main)) ; Mendonça, Tania Melo (CERN) ; Stora, Thierry (CERN) ; Gonzalez Prieto, Borja (SCK-CEN, Mol ; KU Leuven) ; Aerts, Alexander (SCK-CEN, Mol) ; Schumann, Dorothea (PSI, Villigen)
The evaporation behavior of polonium as one of the most hazardous radionuclides produced in spallation based neutron sources with liquid lead-bismuth targets has been quantified in this study. The normalized apparent vapor pressure, i.e. [...]
2014 - Published in : J. Nucl. Mater. 450 (2014) 304-313
5.
Folate Receptor Targeted Alpha-Therapy Using Terbium-149 / Müller, Cristina (PSI, Villigen) ; Reber, Josefine (PSI, Villigen) ; Haller, Stephanie (PSI, Villigen) ; Dorrer, Holger (PSI, Villigen ; U. Bern (main)) ; Köster, Ulli (Laue-Langevin Inst.) ; Johnston, Karl (CERN) ; Zhernosekov, Konstantin (PSI, Villigen) ; Türler, Andreas (PSI, Villigen ; U. Bern (main)) ; Schibli, Roger (PSI, Villigen ; ETH, Zurich (main))
Terbium-149 is among the most interesting therapeutic nuclides for medical applications. It decays by emission of short-range α-particles (Eα = 3.967 MeV) with a half-life of 4.12 h. [...]
2014 - Published in : Pharmaceuticals 7 (2014) 353-365 MDPI Open Access article: PDF;
6.
Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals / Domnanich, Katharina (PSI) ; Ghezzi, Catherine (CHU Grenoble) ; Haddad, Ferid (Arronax Nantes) ; Jensen, Mikael (DTU Riso) ; Kesenheimer, Christian (Tuebingen) ; Köster, Ulli (ILL Grenoble) ; Müller, Cristina (PSI) ; Pichler, Bernd (Tuebingen) ; Pouget, Jean-Pierre (Montpellier) ; Rolle, Anna-Maria (Tuebingen) et al.
CERN-INTC-2014-032 ; INTC-P-312-ADD-1.
- 2014.
Fulltext - Original Document (INTC-P-312)

Se också: liknande författarnamn
22 Türler, A
Vill du bli notifierad om nya resultat till den här sökfrågan?
Sätta upp ett epost-alarm eller starta en prenumeration på RSS-strömmen.
Har du inte funnit vad du söker efter? Försök på andra platser:
Türler, Andreas i Amazon
Türler, Andreas i CERN EDMS
Türler, Andreas i CERN Intranet
Türler, Andreas i CiteSeer
Türler, Andreas i Google Books
Türler, Andreas i Google Scholar
Türler, Andreas i Google Web
Türler, Andreas i IEC
Türler, Andreas i IHS
Türler, Andreas i INSPIRE
Türler, Andreas i ISO
Türler, Andreas i KISS Books/Journals
Türler, Andreas i KISS Preprints
Türler, Andreas i NEBIS
Türler, Andreas i SLAC Library Catalog
Türler, Andreas i Scirus